Colorectal Cancer | Specialty

The OncLive Colorectal Cancer condition center page is a comprehensive resource for clinical news and expert insights on colorectal cancer treatment and management, with a focus on novel therapeutic strategies including checkpoint inhibitors and TKIs across lines of therapy. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in colorectal cancer.

Dr. Kasi on Role of Immunotherapy in mCRC

February 14th 2019

Pashtoon M. Kasi, MD, MBBS, MS, assistant professor of oncology and senior associate consultant in the Division of Hematology/Oncology at Mayo Clinic, discusses the role of immunotherapy in the treatment of patients with metastatic colorectal cancer.

Improving Care for Patients With Colon/Rectal Cancer

February 14th 2019

Neoadjuvant Strategies for Rectal Cancer

February 14th 2019

Adjuvant Therapy for High-Risk Colon Cancer

February 14th 2019

Patient Stratification in Colon Cancer: ctDNA

February 14th 2019

Adjuvant Therapy for Early-Stage Colon Cancer

February 14th 2019

Relapsed/Refractory mCRC: Treatment Dosing Strategies

February 14th 2019

Treatment Recommendations for Relapsed/Refractory mCRC

February 14th 2019

Rationale for I-O in mCRC

February 14th 2019

Management of NTRK Fusions in CRC

February 14th 2019

Triplet Regimens for BRAF V600E-Positive mCRC

February 14th 2019

Sequencing Therapy in CRC: REVERCE Trial

February 14th 2019

Sequencing Therapy in CRC: E7208 Trial

February 14th 2019

Maintenance Strategies for Patients With mCRC

February 14th 2019

EGFR Therapy in Left-Sided CRC

February 14th 2019

Recommendations for Molecular Testing in mCRC

February 14th 2019

EGFR Therapy for Right-Sided CRC

February 14th 2019

Dr. Eng on the Treatment Landscape in Metastatic Colorectal Cancer

February 13th 2019

Cathy Eng, MD, professor of gastrointestinal medical oncology, The University of Texas MD Anderson Cancer Center, discusses the treatment landscape in newly diagnosed metastatic colorectal cancer (mCRC).

Dr. Lee on Differences Between HIPEC and PIPAC in mCRC

February 9th 2019

Byrne Lee, MD, chief, Upper GI and Mixed Tumor Surgery Service, associate professor of surgical oncology, City of Hope, discusses the differences between HIPEC and PIPAC in the treatment of patients with metastatic colorectal cancer.

Microbial Metabolomics: A Search for the Missing Link to Cancer

February 8th 2019

Thanks to technological advances, the past several decades have witnessed a blossoming appreciation of the varied composition of these microbial communities, their complex and dynamic relationship with the host, and the way they affect health and disease.